Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Equity: 2014-2025

Historic Return on Equity for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Sep 2025 value amounting to 0.13%.

  • Amphastar Pharmaceuticals' Return on Equity fell 9.00% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year decrease of 9.00%. This contributed to the annual value of 0.22% for FY2024, which is 2.00% down from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Return on Equity is 0.13%, which was down 20.11% from 0.16% recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Return on Equity high stood at 0.24% for Q2 2024, and its period low was 0.00% during Q1 2021.
  • In the last 3 years, Amphastar Pharmaceuticals' Return on Equity had a median value of 0.20% in 2024 and averaged 0.19%.
  • In the last 5 years, Amphastar Pharmaceuticals' Return on Equity dropped by 16bps in 2021 and then increased by 18bps in 2022.
  • Amphastar Pharmaceuticals' Return on Equity (Quarterly) stood at 0.15% in 2021, then rose by 2bps to 0.17% in 2022, then grew by 5bps to 0.22% in 2023, then decreased by 2bps to 0.20% in 2024, then dropped by 9bps to 0.13% in 2025.
  • Its Return on Equity stands at 0.13% for Q3 2025, versus 0.16% for Q2 2025 and 0.18% for Q1 2025.